Titan Pharmaceuticals
TTNP
#10403
Rank
A$9.19 M
Marketcap
A$6.91
Share price
-3.76%
Change (1 day)
33.37%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$7.06 Million, an increase over its 2023 earnings that were of -A$8.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-38.73%
2024 -A$7.06 Million-15.5%
2023 -A$8.35 Million-45.43%
2022 -A$15.3 Million16.29%
2021 -A$13.16 Million-907.36%
2020 A$1.62 M-106.6%
2019 -A$24.68 Million82.4%
2018 -A$13.53 Million-36.93%
2017 -A$21.45 Million-378.62%
2016 A$7.69 M-145.53%
2015 -A$16.91 Million369.37%
2014 -A$3.61 Million-125.9%
2013 A$13.9 M-177.74%
2012 -A$17.9 Million13.59%
2011 -A$15.75 Million74.37%
2010 -A$9.04 Million3.61%
2009 -A$8.72 Million
2007 -A$27.64 Million12.08%
2006 -A$24.66 Million-28.65%
2005 -A$34.56 Million-10.03%
2004 -A$38.41 Million-6.08%
2003 -A$40.9 Million-14.76%
2002 -A$47.98 Million32.52%
2001 -A$36.21 Million27.55%
2000 -A$28.39 Million62.5%
1999 -A$17.47 Million4.04%
1998 -A$16.79 Million49.33%
1997 -A$11.25 Million-27.88%
1996 -A$15.6 Million13.04%
1995 -A$13.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-A$0.19 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$18 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.39 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.56 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.61 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
A$39.18 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA